HYPMY
Price
$4.26
Change
-$0.25 (-5.54%)
Updated
May 21 closing price
Capitalization
5.79B
KMDA
Price
$6.83
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Capitalization
306.49M
82 days until earnings call
Interact to see
Advertisement

HYPMY vs KMDA

Header iconHYPMY vs KMDA Comparison
Open Charts HYPMY vs KMDABanner chart's image
Hypera SA
Price$4.26
Change-$0.25 (-5.54%)
Volume$289
Capitalization5.79B
Kamada
Price$6.83
Change-$0.00 (-0.00%)
Volume$102
Capitalization306.49M
HYPMY vs KMDA Comparison Chart
Loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HYPMY vs. KMDA commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HYPMY is a Hold and KMDA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (HYPMY: $4.26 vs. KMDA: $6.83)
Brand notoriety: HYPMY and KMDA are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HYPMY: 4% vs. KMDA: 86%
Market capitalization -- HYPMY: $5.79B vs. KMDA: $306.49M
HYPMY [@Pharmaceuticals: Other] is valued at $5.79B. KMDA’s [@Pharmaceuticals: Other] market capitalization is $306.49M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HYPMY’s FA Score shows that 2 FA rating(s) are green whileKMDA’s FA Score has 0 green FA rating(s).

  • HYPMY’s FA Score: 2 green, 3 red.
  • KMDA’s FA Score: 0 green, 5 red.
According to our system of comparison, HYPMY is a better buy in the long-term than KMDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KMDA’s TA Score shows that 7 TA indicator(s) are bullish.

  • KMDA’s TA Score: 7 bullish, 2 bearish.

Price Growth

HYPMY (@Pharmaceuticals: Other) experienced а +0.54% price change this week, while KMDA (@Pharmaceuticals: Other) price change was -3.12% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.10%. For the same industry, the average monthly price growth was +10.36%, and the average quarterly price growth was +30.06%.

Reported Earning Dates

HYPMY is expected to report earnings on Mar 21, 2025.

KMDA is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.10% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HYPMY($5.79B) has a higher market cap than KMDA($306M). KMDA has higher P/E ratio than HYPMY: KMDA (37.43) vs HYPMY (15.95). HYPMY YTD gains are higher at: 43.595 vs. KMDA (15.365). HYPMY has higher annual earnings (EBITDA): 2.86B vs. KMDA (22.4M). HYPMY has higher revenues than KMDA: HYPMY (7.75B) vs KMDA (143M).
HYPMYKMDAHYPMY / KMDA
Capitalization5.79B306M1,892%
EBITDA2.86B22.4M12,750%
Gain YTD43.59515.365284%
P/E Ratio15.9537.4343%
Revenue7.75B143M5,420%
Total CashN/A55.6M-
Total DebtN/A8.82M-
FUNDAMENTALS RATINGS
HYPMY vs KMDA: Fundamental Ratings
HYPMY
KMDA
OUTLOOK RATING
1..100
326
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
69
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10078
PRICE GROWTH RATING
1..100
3846
P/E GROWTH RATING
1..100
1243
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HYPMY's Valuation (11) in the null industry is somewhat better than the same rating for KMDA (69) in the Biotechnology industry. This means that HYPMY’s stock grew somewhat faster than KMDA’s over the last 12 months.

HYPMY's Profit vs Risk Rating (100) in the null industry is in the same range as KMDA (100) in the Biotechnology industry. This means that HYPMY’s stock grew similarly to KMDA’s over the last 12 months.

KMDA's SMR Rating (78) in the Biotechnology industry is in the same range as HYPMY (100) in the null industry. This means that KMDA’s stock grew similarly to HYPMY’s over the last 12 months.

HYPMY's Price Growth Rating (38) in the null industry is in the same range as KMDA (46) in the Biotechnology industry. This means that HYPMY’s stock grew similarly to KMDA’s over the last 12 months.

HYPMY's P/E Growth Rating (12) in the null industry is in the same range as KMDA (43) in the Biotechnology industry. This means that HYPMY’s stock grew similarly to KMDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KMDA
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
Bearish Trend 1 day ago
67%
MACD
ODDS (%)
Bearish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 9 days ago
66%
Declines
ODDS (%)
Bearish Trend 1 day ago
68%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EGOIX17.99N/A
N/A
Allspring Large Cap Core Inst
CSCZX47.71N/A
N/A
Columbia Small Cap Value I Inst
SESGX22.80N/A
N/A
Sit ESG Growth S
DHIIX19.04N/A
N/A
Diamond Hill International I
ATHWX19.55N/A
N/A
American Century Heritage R

HYPMY and

Correlation & Price change

A.I.dvisor tells us that HYPMY and AYRWF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HYPMY and AYRWF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPMY
1D Price
Change %
HYPMY100%
N/A
AYRWF - HYPMY
23%
Poorly correlated
+0.58%
PLNH - HYPMY
21%
Poorly correlated
+2.35%
CPIX - HYPMY
20%
Poorly correlated
+2.62%
GLASF - HYPMY
20%
Poorly correlated
-1.64%
KMDA - HYPMY
20%
Poorly correlated
N/A
More

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and CRDL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and CRDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
N/A
CRDL - KMDA
30%
Poorly correlated
+0.94%
RDY - KMDA
29%
Poorly correlated
-0.35%
OGI - KMDA
28%
Poorly correlated
+2.24%
NXSCF - KMDA
27%
Poorly correlated
N/A
SGIOY - KMDA
27%
Poorly correlated
+2.26%
More